TY - JOUR
T1 - Transoral robotic surgery for oropharyngeal squamous cell carcinoma
AU - Schmitt, Nicole C.
AU - Duvvuri, Umamaheswar
N1 - Publisher Copyright:
© 2015 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Purpose of review This article reviews recent information on outcomes, indications, techniques, and cost of transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC). New information on comparisons between TORS, conventional surgery techniques, and chemoradiation is also highlighted. Recent findings Consistent with prior reports, recent studies show excellent oncologic and functional outcomes with TORS for OPSCC. As surgeon experience with this relatively new technique has increased, outcomes continue to improve and complications are rare. TORS may also have a role in management of carcinoma of unknown primary site. Compared with other treatment modalities, TORS for OPSCC may result in similar oncologic outcomes, improved functional outcomes, and decreased cost. Summary TORS for OPSCC results in excellent functional and oncologic outcomes. Randomized clinical trials are needed to compare TORS with adjuvant therapy to definitive chemoradiation and will determine whether adjuvant therapy and associated morbidity can be decreased without compromising survival.
AB - Purpose of review This article reviews recent information on outcomes, indications, techniques, and cost of transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC). New information on comparisons between TORS, conventional surgery techniques, and chemoradiation is also highlighted. Recent findings Consistent with prior reports, recent studies show excellent oncologic and functional outcomes with TORS for OPSCC. As surgeon experience with this relatively new technique has increased, outcomes continue to improve and complications are rare. TORS may also have a role in management of carcinoma of unknown primary site. Compared with other treatment modalities, TORS for OPSCC may result in similar oncologic outcomes, improved functional outcomes, and decreased cost. Summary TORS for OPSCC results in excellent functional and oncologic outcomes. Randomized clinical trials are needed to compare TORS with adjuvant therapy to definitive chemoradiation and will determine whether adjuvant therapy and associated morbidity can be decreased without compromising survival.
KW - oropharyngeal squamous cell carcinoma
KW - transoral robotic surgery
KW - unknown primary carcinoma
UR - http://www.scopus.com/inward/record.url?scp=84953342210&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84953342210&partnerID=8YFLogxK
U2 - 10.1097/MOO.0000000000000136
DO - 10.1097/MOO.0000000000000136
M3 - Review article
C2 - 25692632
AN - SCOPUS:84953342210
SN - 1068-9508
VL - 23
SP - 127
EP - 131
JO - Current Opinion in Otolaryngology and Head and Neck Surgery
JF - Current Opinion in Otolaryngology and Head and Neck Surgery
IS - 2
ER -